- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
前期的强势行情已经结束，投资者及时卖出股票为为宜。
- 中期趋势：
回落整理中且下跌有加速趋势。
- 长期趋势：
已有476家主力机构披露2026-06-30报告期持股数据，持仓量总计2.52亿股，占流通A股44.47%
- 波段诊断：
-
技术面诊股
诊断结果：4.1技术面打败了27%的股票
技术面评分前10的股票
近期的平均成本为54.47元。多头行情中，目前处于回落整理阶段且下跌有加速趋势。
平均成本
近期的平均成本为54.47元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"54.47","date":1791792907,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，跑输行业平均水平。
[{"date":"2026.10.13","stock":"-3.14","trade":"-1.36","ind":"-0.25"},{"date":"2026.10.12","stock":"1.63","trade":"-2.34","ind":"-2.03"},{"date":"2026.10.09","stock":"-0.52","trade":"0.82","ind":"0.17"},{"date":"2026.10.08","stock":"-5.02","trade":"-3.10","ind":"-2.07"},{"date":"2026.09.30","stock":"3.42","trade":"3.11","ind":"-0.11"},{"date":"2026.09.29","stock":"-0.58","trade":"-0.15","ind":"0.34"},{"date":"2026.09.28","stock":"-0.02","trade":"-1.56","ind":"-3.44"},{"date":"2026.09.24","stock":"-2.89","trade":"-2.13","ind":"-2.34"},{"date":"2026.09.23","stock":"1.14","trade":"0.90","ind":"-0.64"},{"date":"2026.09.22","stock":"-1.95","trade":"0.79","ind":"-0.05"},{"date":"2026.09.21","stock":"2.79","trade":"5.10","ind":"0.65"},{"date":"2026.09.18","stock":"0.67","trade":"2.54","ind":"1.72"},{"date":"2026.09.17","stock":"0.37","trade":"1.45","ind":"-0.33"},{"date":"2026.09.16","stock":"1.77","trade":"2.42","ind":"1.26"},{"date":"2026.09.15","stock":"-1.05","trade":"-1.54","ind":"-0.72"},{"date":"2026.09.14","stock":"6.82","trade":"3.99","ind":"-0.64"},{"date":"2026.09.11","stock":"-1.88","trade":"-2.77","ind":"-1.08"},{"date":"2026.09.10","stock":"-1.59","trade":"-2.42","ind":"-0.77"},{"date":"2026.09.09","stock":"2.59","trade":"-0.75","ind":"0.15"},{"date":"2026.09.08","stock":"8.20","trade":"3.08","ind":"-0.52"},{"date":"2026.09.07","stock":"-1.48","trade":"0.78","ind":"1.91"}]
泰格医药,深证成指,医疗服务指数
压力支撑
该股压力位为54.50元，支撑位为53.21元。
[{"text":"\u538b\u529b\u4f4d","value":"54.50","date":1791820800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"53.21","date":1791820800,"color":"0x0b52a1"}]
多空趋势
多头行情中，目前处于回落整理阶段且下跌有加速趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.3资金面打败了40%的股票
主力控盘前10的股票
行业资金
医疗服务行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：10月13日 20:30
| 机构今日流向(万元) | -54.12 | 机构5日流向(万元) | -2249.21 |
| 机构10日流向(万元) | -7819.05 | 机构20日流向(万元) | -4459.97 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少1590.9万股，其中基金净减仓65家，主力净减仓273家，请投资者中长期谨慎为宜。
截止2026-06-30，共476家主力机构（基金473家，一般法人1家，券商集合理财2家），持仓量总计25181.56万股，占流通A股44.47%
其中，基金持仓与2025-12-31相比：
增仓：104家 ，增持 8380.60万股
减仓：169家 ，减持 2982.67万股
新出现在主力名单中：182家 ，持有3208.14万股
从主力名单中消失：455家 ，原持有7565.06万股
其中，基金持仓与2025-12-31相比：
增仓：104家 ，增持 8380.60万股
减仓：169家 ，减持 2982.67万股
新出现在主力名单中：182家 ，持有3208.14万股
从主力名单中消失：455家 ，原持有7565.06万股
消息面诊股
诊断结果：5.8消息面打败了29%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 泰格医药盘中跌超6%
2026-10-13 - 港股CRO概念股全线重挫
2026-10-13 - 泰格医药：10月12日获融资买入2884.30万元
2026-10-13 - 上市公司加大回购力度 专项贷款额逐季放量
2026-10-13 - CXO+AI制药+创新药，产业链19家核心公司
2026-10-12 - 券商观点|医药生物行业周报：CXO景气延续，AI制
2026-10-12 - 券商观点|医药行业周报：RAY1225减重III期
2026-10-12 - 泰格医药：10月9日获融资买入3734.61万元
2026-10-12 - 10家CXO半年盘点：订单大涨，业绩分化
2026-10-12 - AI制药越快，中国实验室越忙
2026-10-10
消息列表
| 利空 | 重大事项 | 公司违规：处罚类型 | 2026-09-12 |
| 一般消息 | 股东大会 | 内资股类别股东大会 | 2026-09-04 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-08-29 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2026-06-30 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-05-12 |
| 利好 | 分红转增 | 10派1.26元(含税) | 2026-03-31 |
| 一般消息 | 重大事项 | 关联交易 | 2026-03-31 |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2026-01-29 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 4条 | 1条 | 3条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：6.3行业面打败了80%的股票
医疗服务行业最新资金流向
近10日来该行业走势总体向下，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势总体向下，接近大盘。
[{"date":"2026.10.13","price":"-0.25","value":"-1.36"},{"date":"2026.10.12","price":"-2.03","value":"-2.34"},{"date":"2026.10.09","price":"0.17","value":"0.82"},{"date":"2026.10.08","price":"-2.07","value":"-3.10"},{"date":"2026.09.30","price":"-0.11","value":"3.11"},{"date":"2026.09.29","price":"0.34","value":"-0.15"},{"date":"2026.09.28","price":"-3.44","value":"-1.56"},{"date":"2026.09.24","price":"-2.34","value":"-2.13"},{"date":"2026.09.23","price":"-0.64","value":"0.90"},{"date":"2026.09.22","price":"-0.05","value":"0.79"},{"date":"2026.09.21","price":"0.65","value":"5.10"},{"date":"2026.09.18","price":"1.72","value":"2.54"},{"date":"2026.09.17","price":"-0.33","value":"1.45"},{"date":"2026.09.16","price":"1.26","value":"2.42"},{"date":"2026.09.15","price":"-0.72","value":"-1.54"},{"date":"2026.09.14","price":"-0.64","value":"3.99"},{"date":"2026.09.11","price":"-1.08","value":"-2.77"},{"date":"2026.09.10","price":"-0.77","value":"-2.42"},{"date":"2026.09.09","price":"0.15","value":"-0.75"},{"date":"2026.09.08","price":"-0.52","value":"3.08"},{"date":"2026.09.07","price":"1.91","value":"0.78"}]
深证成指,医疗服务行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | - | 57.56% | 1.81% | 分 |
| 2 | 诺禾致源 | 48.91% | 8.73% | 5.5分 |
| 3 | 南模生物 | 42.64% | 1.88% | 5.2分 |
| 4 | 澳洋健康 | 27.86% | 7.83% | 5.2分 |
| 5 | 贝瑞基因 | 27.29% | 12.35% | 6.3分 |
| 6 | 南华生物 | 23.49% | -5.93% | 5.8分 |
| 8 | 成都先导 | 21.43% | -12.18% | 4.1分 |
| 10 | 奥浦迈 | 19.49% | -8.80% | 4.8分 |
| 12 | 华大基因 | 16.46% | -2.74% | 5.6分 |
| 14 | 迪安诊断 | 14.16% | 1.83% | 6.5分 |
| 16 | 九洲药业 | 11.63% | 2.09% | 5.9分 |
| 18 | 毕得医药 | 10.87% | -11.28% | 4.3分 |
| 20 | 金域医学 | 10.09% | 2.76% | 6.0分 |
| 22 | 兰卫医学 | 7.46% | -4.67% | 5.7分 |
| 24 | 美迪西 | 7.13% | -5.71% | 5.3分 |
| 26 | 药康生物 | 4.80% | -6.46% | 4.9分 |
| 28 | 美年健康 | 3.46% | 7.16% | 6.6分 |
| 30 | 盈康生命 | 2.90% | 0.26% | 6.2分 |
| 32 | 药明康德 | 2.68% | -2.06% | 5.4分 |
| 34 | 金凯生科 | 0.63% | -6.43% | 5.0分 |
| 36 | 皓元医药 | -0.67% | -9.47% | 4.3分 |
| 38 | 海特生物 | -1.00% | -0.64% | 4.6分 |
| 40 | 睿智医药 | -1.45% | -8.09% | 4.8分 |
| 42 | 百花医药 | -3.33% | -10.27% | 4.5分 |
| 44 | 大东方 | -4.38% | 2.08% | 5.0分 |
| 46 | 通策医疗 | -5.17% | 1.06% | 5.9分 |
| 48 | 阳光诺和 | -5.45% | -5.17% | 4.5分 |
| 50 | 三博脑科 | -5.98% | 0.68% | 5.5分 |
| 52 | 创新医疗 | -9.04% | -2.17% | 4.8分 |
| 54 | 诚达药业 | -17.18% | -0.38% | 4.8分 |
| 56 | 百奥赛图 | -23.22% | -24.73% | 4.9分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 安信证券 | 2012-09-04 | 增持 | 增持 |
| 长江证券 | 2012-09-02 | 增持 | - |
更多>>行业资讯
- 2012-09-13北京药监局通知全市停用8家企业中药饮片
- 2012-09-13澳洲股指周四收跌0.5% 医疗及消费股领跌
- 2012-09-13基层中医药服务能力将获提升
- 2012-09-132012中国医疗卫生产业发展论坛召开
- 2012-09-13医药行业：媒体称新版基药目录品种将扩至700个
- 2012-09-13陕西县级公立医院改革全面推开
- 2012-09-138月中山CPI 环比涨0.1%
- 2012-09-13中金公司：医药板块选股坚持“稳健业绩+成长空间预期
- 2012-09-13澳洲股指周四盘初跌0.5% 医疗及消费股领跌
- 2012-09-13感冒药“实名制”个人信息易“走光”？ 法国立法严管
基本面诊股
[ 截止日期：2026-06-30 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 46/102 ， 41/102。
[{"date":"2026-06-30","value":"-2.04","vol":"2.39"},{"date":"2026-03-31","value":"0.23","vol":"0.96"},{"date":"2025-12-31","value":"4.27","vol":"2.21"},{"date":"2025-09-30","value":"4.88","vol":"3.24"},{"date":"2025-06-30","value":"1.86","vol":"2.24"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-2.04 | 0.23 | 4.27 | 4.88 | 1.86 |
| 行业(%) | 2.39 | 0.96 | 2.21 | 3.24 | 2.24 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"27.53","vol":"34.37"},{"date":"2026-03-31","value":"26.64","vol":"34.16"},{"date":"2025-12-31","value":"27.41","vol":"34.36"},{"date":"2025-09-30","value":"29.16","vol":"36.06"},{"date":"2025-06-30","value":"30.09","vol":"36.21"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
27.53 | 26.64 | 27.41 | 29.16 | 30.09 |
| 行业(%) | 34.37 | 34.16 | 34.36 | 36.06 | 36.21 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 19/102 ， 52/102。
[{"date":"2026-06-30","value":"14.06","vol":"16.81"},{"date":"2026-03-31","value":"15.17","vol":"16.75"},{"date":"2025-12-31","value":"3.48","vol":"8.22"},{"date":"2025-09-30","value":"-0.82","vol":"3.06"},{"date":"2025-06-30","value":"-3.21","vol":"2.87"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
14.06 | 15.17 | 3.48 | -0.82 | -3.21 |
| 行业(%) | 16.81 | 16.75 | 8.22 | 3.06 | 2.87 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"-207.78","vol":"134.87"},{"date":"2026-03-31","value":"-70.36","vol":"79.49"},{"date":"2025-12-31","value":"119.15","vol":"23.26"},{"date":"2025-09-30","value":"25.45","vol":"20.05"},{"date":"2025-06-30","value":"-22.22","vol":"-63.31"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-207.78 | -70.36 | 119.15 | 25.45 | -22.22 |
| 行业(%) | 134.87 | 79.49 | 23.26 | 20.05 | -63.31 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 47/102 ， 2/102。
[{"date":"2026-06-30","value":"0.13","vol":"0.22"},{"date":"2026-03-31","value":"0.06","vol":"0.10"},{"date":"2025-12-31","value":"0.24","vol":"0.44"},{"date":"2025-09-30","value":"0.17","vol":"0.32"},{"date":"2025-06-30","value":"0.11","vol":"0.21"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.13 | 0.06 | 0.24 | 0.17 | 0.11 |
| 行业(次) | 0.22 | 0.10 | 0.44 | 0.32 | 0.21 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"50.17","vol":"7.15"},{"date":"2026-03-31","value":"27.12","vol":"3.44"},{"date":"2025-12-31","value":"135.03","vol":"15.84"},{"date":"2025-09-30","value":"93.82","vol":"10.95"},{"date":"2025-06-30","value":"60.13","vol":"7.15"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
50.17 | 27.12 | 135.03 | 93.82 | 60.13 |
| 行业(次) | 7.15 | 3.44 | 15.84 | 10.95 | 7.15 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 39/102 ， 24/102。
[{"date":"2026-06-30","value":"5.67","vol":"15.88"},{"date":"2026-03-31","value":"17.64","vol":"0.86"},{"date":"2025-12-31","value":"20.95","vol":"20.95"},{"date":"2025-09-30","value":"18.64","vol":"16.52"},{"date":"2025-06-30","value":"12.49","vol":"16.38"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 5.67 | 17.64 | 20.95 | 18.64 | 12.49 |
| 行业 | 15.88 | 0.86 | 20.95 | 16.52 | 16.38 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.59","vol":"0.94"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.58","vol":"0.89"},{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.55","vol":"0.91"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.59 | - | 0.58 | - | 0.55 |
| 行业 | 0.94 | 0.00 | 0.89 | 0.01 | 0.91 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 15/102 ， 35/102。
[{"date":"2026-06-30","value":"2.49","vol":"3.00"},{"date":"2026-03-31","value":"2.30","vol":"3.37"},{"date":"2025-12-31","value":"2.18","vol":"3.64"},{"date":"2025-09-30","value":"2.16","vol":"3.67"},{"date":"2025-06-30","value":"1.83","vol":"3.57"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.49 | 2.30 | 2.18 | 2.16 | 1.83 |
| 行业 | 3.00 | 3.37 | 3.64 | 3.67 | 3.57 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"2.37","vol":"2.40"},{"date":"2026-03-31","value":"2.22","vol":"2.78"},{"date":"2025-12-31","value":"2.10","vol":"3.00"},{"date":"2025-09-30","value":"2.08","vol":"2.94"},{"date":"2025-06-30","value":"1.76","vol":"2.87"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.37 | 2.22 | 2.10 | 2.08 | 1.76 |
| 行业 | 2.40 | 2.78 | 3.00 | 2.94 | 2.87 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 40/102 ， 38/102。
[{"date":"2026-06-30","value":"17.21","vol":"33.06"},{"date":"2026-03-31","value":"14.71","vol":"32.97"},{"date":"2025-12-31","value":"14.47","vol":"32.98"},{"date":"2025-09-30","value":"14.16","vol":"32.60"},{"date":"2025-06-30","value":"15.93","vol":"33.58"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
17.21 | 14.71 | 14.47 | 14.16 | 15.93 |
| 行业(%) | 33.06 | 32.97 | 32.98 | 32.60 | 33.58 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.25","vol":"0.90"},{"date":"2026-03-31","value":"0.20","vol":"0.97"},{"date":"2025-12-31","value":"0.20","vol":"0.97"},{"date":"2025-09-30","value":"0.19","vol":"0.92"},{"date":"2025-06-30","value":"0.22","vol":"0.96"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.25 | 0.20 | 0.20 | 0.19 | 0.22 |
| 行业(%) | 0.90 | 0.97 | 0.97 | 0.92 | 0.96 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 华源证券 | 2026-09-22 | 增持 | |
| 平安证券 | 2026-09-20 | 增持 | |
| 国盛证券 | 2026-09-12 | 买入 | |
| 中泰证券 | 2026-09-06 | 买入 | 买入 |
| 中邮证券 | 2026-09-03 | 买入 | |
| 中信建投证券 | 2026-09-03 | 买入 |
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"20.07","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"20.25","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"4.05","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"8.88","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"6.71","blueLineValue":"0.78","type":"YC"}]